Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Feb 06, 2021 5:33pm
321 Views
Post# 32494145

Modivolve is marking real progress backed by revenue numbers

Modivolve is marking real progress backed by revenue numbers
Medivolve situation is different compared to the past. In the past, Anonymous could manipulate Medivolve as investors see forward-looking progress or plan but no revenue. So people buy, QSC stock price goes up, then Anonymous start their manipulation and drive down the stock price without follow-up updates. 
 
Now, it is a different story, Modivolve is marking real progress backed by revenue numbers. Yes, Anonymous can still manipulate MEDV, but they can do it only for the short term. Medivolve is issuing updates every other day showing, revenue numbers getting better and better. New collection sites coming online every week, bringing more revenue. 
 
I don't know who is selling, as Anonymous. One of the businesses that got paid from Medivolve with shares or someone, shorting MEDV. When you analyze data and watch trading orders in real-time, it does point to short selling. Whatever the case is, no one continues this forever. Once they are out of this option, Medivolve can start climbing up.
 
In my lifetime as a stock trader, I see Medivolve have many options. Logic is to let these people sell, and when you see they don't have much left, bring in the hammer. That can be in many different ways. Medivolve can start TV commercial advertising collection sites, arrange an interview with BNN or arrange a business press conference. Hire an investor relation, start selling more products or services through collection sites. 
 
The revenue, Medivolve is generating from collection sites, Sanity Columbia and partnership with RESAAS.  Now, they will be offering Nuturell's COVID-19 Surface Shield Technology. Medivolve, also working with Marvel Diagnostics to bring in non-invasive low-cost BlowFISH, will be a disruptive technology. 
 
I don't think Anonymous can manipulate Medivolve for long. The company announced 62 collection sites up and running.  I see 14 out of 15 Texas locations started taking appointments from today 3 more compared to last week. Many of the Florida locations shows taking appointments from Monday. So progress continues.
 
Once Medivolve management decided enough is enough. They can move this stock to its real value very fast. All they need is a $100-$220k budget, and they can destroy these shorts. I am noting going to put numbers to the stock price.  Instead, I challenge everyone to spend a few hours searching, a company with $20-$30 million monthly revenue and see what market cap they are trading. You will get your answer to what price Medivolve should be trading or what should be a reasonable market cap.  
<< Previous
Bullboard Posts
Next >>